引用本文:韦爱芳,蓝 川,张继军.紫杉醇联合顺铂治疗晚期非小细胞肺癌46例的临床观察[J].中国临床新医学,2010,3(7):663-665.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1294次   下载 931 本文二维码信息
码上扫一扫!
分享到: 微信 更多
紫杉醇联合顺铂治疗晚期非小细胞肺癌46例的临床观察
韦爱芳,蓝 川,张继军
547000 广西,河池市人民医院内五科(肿瘤血液内科)
摘要:
[摘要] 目的 观察国产紫杉醇联合顺铂治疗Ⅲ~Ⅳ期非小细胞肺癌(NSCLC)的近期疗效和毒副反应。方法 选Ⅲ~Ⅳ期NSCLC病例46例,用紫杉醇150 mg/m2加入5%葡萄糖注射液500 ml中静脉滴注3 h,d1,顺铂60 mg加入生理盐水注射液100 ml中静脉滴注,d2、3,3~4周为1周期,2~5周期后评价疗效。结果 全组46例有效率为39.13%(18/46),主要毒副反应为血液毒性反应、脱发及消化道反应。结论 紫杉醇联合顺铂治疗晚期NSCLC有较好疗效,毒副反应较小,可以耐受。
关键词:  紫杉醇  顺铂  化疗  非小细胞肺癌
DOI:10.3969/j.issn.1674-3806.2010.07.25
分类号:R 734.2
基金项目:
Paclitaxel combined with cisplatin for treatment of advanced non-small cell lung cancer:Clinical observation of 46 cases
WEI Ai-fang,LAN Chuan,ZHANG Ji-jun
Hechi City People′s Hospital, Guangxi 547000,China
Abstract:
[Abstract] Objective To observe short-term efficacy and toxicity of paclitaxel and cisplatin in the treatment of Ⅲ-Ⅳ non-small cell lung cancer.Methods Forty-six cases of Ⅲ-Ⅳ non-small cell lung cancer were treared by intravenous drip of paclitaxel 150 mg/m2 in 5% glucose injection 500 ml, within 3 hours, d1; cisplatin 60 mg in 100 ml normal saline injection, intravenous drip, d2,3. A cycle lasted for 3 to 4 weeks.After 2 to 5 cycles the treatment effects were evaluated.Results In Forty-six cases the response rate was 39.13%(18/46). The main toxicities inclnded blood toxicity, alopecia, and digestive tract reaction.Conclusion Paclitaxel combined with cisplatin for treatment of advanced non-small cell lung cancer have better efficacy, less toxicity and can be tolerated.
Key words:  Paclitaxel  Cisplatin  Chemotherapy  Non-small cell lung cancer